Dr. Taylor's laboratory investigates how inflammation or injury leads to the transition from acute pain to chronic pathological pain in the peripheral nerve, spinal cord, and brain. They employ advanced techniques to study the molecular neurobiology of pain sensitization and opioid dependence, focusing on the role of endogenous neuropeptide receptor signaling in suppressing chronic pain after traumatic injury. By understanding the body's natural mechanisms to prevent chronic pain, they aim to develop new pharmacotherapeutic approaches that can replace addictive opioids for patients with intractable pain. Dr. Taylor's laboratory has secured over $17 million in research grants and published numerous peer-reviewed articles, including a significant discovery on the long-term pain relief effects of constitutive activity of opioid receptors. With expertise in various disciplines, their research continually pushes the boundaries of translational medicine to advance the understanding and treatment of chronic pain and opioid dependence.